Date Posted: August 8, 2026

This Billing and Coding Article has been revised under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Effective Date: April 6, 2026

Summary of Changes:

Under Article Text subheading Additional Test-specific Indications, Limitations and Instructions revised 1st sentence to read "neoadjuvant breast cancers (Signatera and NeXT Personal)". Formatting was corrected throughout the article. This revision is due to a new covered test that has successfully completed a TA and is effective for 04/06/2026.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.